# Glaxosmithkline Intellectual Property (No.3) (Glaxosmithkline Intellectual Property (No.3) Limited) Private limited company registered in Stevenage, classed under “Other professional, scientific and technical activities n.e.c.”. - Company number: 11480952 - Status: Active - Type: Private limited company - Incorporated: 24 July 2018 - Registered office: Gsk Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY - Location: Stevenage - Activity: Other professional, scientific and technical activities n.e.c. ## Latest filed profit No profit figure in its latest filed accounts. Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers. ## Questions people ask ### What does Glaxosmithkline Intellectual Property (No.3) do? Private limited company registered in Stevenage, classed under “Other professional, scientific and technical activities n.e.c.”. ### How much turnover does Glaxosmithkline Intellectual Property (No.3) make? Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/glaxosmithkline-intellectual-property-no3-11480952 ### Is Glaxosmithkline Intellectual Property (No.3) profitable? Glaxosmithkline Intellectual Property (No.3)'s profit isn't public: small companies may file without a profit and loss account. ### Who runs and owns Glaxosmithkline Intellectual Property (No.3)? Its directors are Edinburgh Pharmaceutical Industries Limited, Cristina Barcelo Iglesias, Anna Mary Harcourt Fent, Demet Gurunlu Russ, Graham Paul Rivers and 3 more. Its owners are shown to subscribers. ### Where is Glaxosmithkline Intellectual Property (No.3) based? Its registered office is Gsk Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, in Stevenage. ### When was Glaxosmithkline Intellectual Property (No.3) founded? Glaxosmithkline Intellectual Property (No.3) Limited was incorporated on 24 July 2018. ### Is Glaxosmithkline Intellectual Property (No.3) still trading? The register lists Glaxosmithkline Intellectual Property (No.3) Limited as active. ## Timeline Recent filings and changes at Companies House. - 2026-08-20: Audit exemption subsidiary accounts made up to 31 December 2025 - 2026-08-20: Consolidated accounts of parent company for subsidiary company period ending 31/12/25 - 2026-08-20: Audit exemption statement of guarantee by parent company for period ending 31/12/25 (and 5 more like it since 20 May 2021) - 2026-08-20: Notice of agreement to exemption from audit of accounts for period ending 31/12/25 - 2025-08-19: Audit exemption subsidiary accounts made up to 31 December 2024 - 2025-08-19: Consolidated accounts of parent company for subsidiary company period ending 31/12/24 - 2025-08-19: Notice of agreement to exemption from audit of accounts for period ending 31/12/24 - 2025-07-15: Appointment of Mrs Anna Mary Harcourt Fent as a director on 10 July 2025 - 2025-07-09: Termination of appointment of Jemma-Louise Reynolds as a director on 27 June 2025 - 2024-09-27: Appointment of Mrs Cristina Barcelo Iglesias as a director on 23 September 2024 - 2024-09-20: Director's details changed for Mrs Demet Gurunlu Russ on 15 July 2024 - 2024-09-17: Director's details changed for Mr Graham Paul Rivers on 11 September 2024 - 2024-09-17: Director's details changed for Mrs Jemma-Louise Reynolds on 11 September 2024 - 2024-09-17: Director's details changed for Mr Adam Walker on 11 September 2024 - 2024-09-17: Director's details changed for Mrs Demet Gurunlu Russ on 11 September 2024 - 2024-09-11: Director's details changed for The Wellcome Foundation Limited on 11 September 2024 - 2024-08-30: Audit exemption subsidiary accounts made up to 31 December 2023 - 2024-08-17: Consolidated accounts of parent company for subsidiary company period ending 31/12/23 - 2024-08-17: Notice of agreement to exemption from audit of accounts for period ending 31/12/23 - 2024-07-31: Termination of appointment of Gregory Maxime Reinaud as a director on 24 July 2024 - 2024-07-18: Register inspection address has been changed (and 1 more like it since 9 June 2023) - 2024-07-12: Appointment of Mrs Demet Gurunlu Russ as a director on 25 June 2024 - 2024-07-05: Termination of appointment of Jill Dawn Anderson as a director on 25 June 2024 - 2024-04-15: Appointment of Mrs Jemma-Louise Reynolds as a director on 4 April 2024 - 2024-02-02: Appointment of Mr Gregory Maxime Reinaud as a director on 30 January 2024 --- Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/glaxosmithkline-intellectual-property-no3-11480952